Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Scientific Reports
|
October 7, 2018
Structural insights into pro-aggregation effects of C. elegans CRAM-1 and its human ortholog SERF2
Meenakshisundaram Balasubramaniam, Srinivas Ayyadevara, Robert J Shmookler Reis
Experimental Gerontology
|
August 22, 2006
Quantitative trait loci define genes and pathways underlying genetic variation in longevity
Robert J Shmookler Reis, Ping Kang, Srinivas Ayyadevara
Metabolic Brain Disease
|
August 4, 2021
Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
Srinivas Ayyadevara, Akshatha Ganne, Meenakshisundaram Balasubramaniam, et al.
Frontiers in Aging Neuroscience
|
August 22, 2022
Machine-learning analysis of intrinsically disordered proteins identifies key factors that contribute to neurodegeneration-related aggregation
Akshatha Ganne, Meenakshisundaram Balasubramaniam, Srinivas Ayyadevara, et al.
Frontiers in Oncology
|
November 18, 2014
A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin
David A Alagpulinsa, Srinivas Ayyadevara, Robert Joseph Shmookler Reis
Plos Genetics
|
April 11, 2009
Positive feedback between transcriptional and kinase suppression in nematodes with extraordinary longevity and stress resistance
Cagdaş Tazearslan, Srinivas Ayyadevara, Puneet Bharill, et al.
Frontiers in Genetics
|
April 2, 2013
Extreme Depletion of PIP3 Accompanies the Increased Life Span and Stress Tolerance of PI3K-null C. elegans Mutants
Puneet Bharill, Srinivas Ayyadevara, Ramani Alla, et al.
Biochimica Et Biophysica Acta
|
May 26, 2009
Extreme-longevity mutations orchestrate silencing of multiple signaling pathways
Robert J Shmookler Reis, Puneet Bharill, Cagdas Tazearslan, et al.
Cancer Biology & Therapy
|
May 22, 2015
A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment
David Abasiwani Alagpulinsa, Shmuel Yaccoby, Srinivas Ayyadevara, et al.
Molecular Cancer Therapeutics
|
January 1, 2016
A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition
David A Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Scientific Reports
|
October 7, 2018
Structural insights into pro-aggregation effects of C. elegans CRAM-1 and its human ortholog SERF2
Meenakshisundaram Balasubramaniam, Srinivas Ayyadevara, Robert J Shmookler Reis
Experimental Gerontology
|
August 22, 2006
Quantitative trait loci define genes and pathways underlying genetic variation in longevity
Robert J Shmookler Reis, Ping Kang, Srinivas Ayyadevara
Metabolic Brain Disease
|
August 4, 2021
Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
Srinivas Ayyadevara, Akshatha Ganne, Meenakshisundaram Balasubramaniam, et al.
Frontiers in Aging Neuroscience
|
August 22, 2022
Machine-learning analysis of intrinsically disordered proteins identifies key factors that contribute to neurodegeneration-related aggregation
Akshatha Ganne, Meenakshisundaram Balasubramaniam, Srinivas Ayyadevara, et al.
Frontiers in Oncology
|
November 18, 2014
A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin
David A Alagpulinsa, Srinivas Ayyadevara, Robert Joseph Shmookler Reis
Plos Genetics
|
April 11, 2009
Positive feedback between transcriptional and kinase suppression in nematodes with extraordinary longevity and stress resistance
Cagdaş Tazearslan, Srinivas Ayyadevara, Puneet Bharill, et al.
Frontiers in Genetics
|
April 2, 2013
Extreme Depletion of PIP3 Accompanies the Increased Life Span and Stress Tolerance of PI3K-null C. elegans Mutants
Puneet Bharill, Srinivas Ayyadevara, Ramani Alla, et al.
Biochimica Et Biophysica Acta
|
May 26, 2009
Extreme-longevity mutations orchestrate silencing of multiple signaling pathways
Robert J Shmookler Reis, Puneet Bharill, Cagdas Tazearslan, et al.
Cancer Biology & Therapy
|
May 22, 2015
A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment
David Abasiwani Alagpulinsa, Shmuel Yaccoby, Srinivas Ayyadevara, et al.
Molecular Cancer Therapeutics
|
January 1, 2016
A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition
David A Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby, et al.
Page
of 7